SecBot SecBot

OSRH

OSR Health, Inc.
OTC· Surgical & Medical Instruments & Apparatus· Inc. DE· CIK 0001840425 Healthcare & Medical Devices
$0.2000 −0.01 (−3.85%)
Oct 26 4:00 PM ET · prev $0.2080
Market cap
$4.1M
Nano cap
Median target
$10.00
+4900% · range $10.00–10.00
Next earnings
Nov 10
in 14 days
1 year
−71.4%
from $0.6990 · Oct 27
30 days
−2.4%
from $0.2050
52-week range
$0.1170–0.8170
−76% from high · low Aug 25
Avg volume 20D
168.3K
Sep 30 spike 994.9K
Short interest
🔒 Subscribers only
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
7
analyzed by SecBot
SecBot read BEARISH 6 reports · 90 days
Balance 4 bearish · 0 bullish · 2 neutral oldest → newest, height = score
Avg score ·High conf. 5/6 ·Next Earnings date, Nov 10, 2026
Strongest BEARISH OSR Health amended its existing license agreement with BCM Europe AG to add a convertible note option as an…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InstitutionsMIXED

    Q2 2026: 1 added (0 new), 1 trimmed or exited.

  • TrendDOWNTREND

    15% below its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
VANGUARD FIDUCIARY TRUST CODOUBLED148,266$46.9K
UBS Group AGNEAR_EXIT580$183.00
GEODE CAPITAL MANAGEMENT, LLCADD105,743$63.8K
UBS Group AGTRIM4,476$2.7K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

12-month targets · 1 analysts

Price is below the lowest target. Median implies +4900%.Targets as of Oct 27, 2026.

Earnings setup

Estimates
Nov 10
reports in 14 days
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 10, 2026
Earnings date
OSRH Q3 2026 Earnings Scheduled — 2026-11-10
Recent
Aug 26, 2026
Listing
Delisted: OSRH — removed from the Nasdaq symbol directory
OSR Health, Inc. - Common Stock
Aug 25, 2026
Listing
Listing Status: OSRH — Normal (was Deficient)
OSR Health, Inc. - Common Stock | Nasdaq Financial Status Indicator D → N
Aug 12, 2026
Earnings date
OSRH Q2 2026 Earnings Scheduled — 2026-08-12
Jul 31, 2026
Short interest
Short Interest: OSRH down 38% to 1.0M shares
Settlement 2026-07-31 | Days to cover: 1.49 | ≈2.99% of shares outstanding (est.)
Jun 15, 2026
Short interest
Short Interest: OSRH up 20% to 1.4M shares
Settlement 2026-06-15 | Days to cover: 1.35 | ≈4.06% of shares outstanding (est.)

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 16, 2026 SEC
OSR Health amended its existing license agreement with BCM Europe AG to add a convertible note option as an…
8-K — Impact 6/10
Oct 2, 2026 SEC
Dr. Constance Hoefer resigned as Chief Scientific Officer of OSR Health, effective immediately on September 30, 2026…
8-K — Impact 3/10
Aug 28, 2026 SEC
OSR Health disclosed that its Nasdaq hearing is scheduled for September 29, 2026, to appeal the Staff's delisting…
8-K — Impact 7/10
Aug 26, 2026 Listing status
Delisted: OSRH — removed from the Nasdaq symbol directory
OSR Health, Inc. - Common Stock
Jun 30, 2026 Inst.
VANGUARD FIDUCIARY TRUST CO — DOUBLED
148,266 shares ($46.9K)
Jun 30, 2026 Inst.
UBS Group AG — NEAR_EXIT
580 shares ($183.00)

SecBot reports

7 filings · 0 bullish · 4 bearish · 3 neutral
All OSRH filing & press-release reports (7)